<DOC>
	<DOCNO>NCT02621762</DOCNO>
	<brief_summary>The study aim determine effect size magnesium bicarbonate supplementation basis future randomize control trial aim T50-guided improvement hard clinical endpoint dialysis patient .</brief_summary>
	<brief_title>Pilot Study Investigate Effects Increased Dialysate Magnesium Dialysate Bicarbonate Calcification Propensity Serum</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>Male female hemodialysis patient ≥ 18 year age Negative pregnancy test female patient childbearing age The patient able understand character individual impact clinical study give write informed consent participate study Start chronic hemodialysis treatment ≥ 3 month ago HCO3 venous plasma ≤23 mmol/L start last dialysis week Magnesium venous plasma ≤ 1.45 mmol/L start first dialysis week T50 ≥ 200 minute . Pregnant lactating subject . A blood pregnancy test perform screen visit female patient childbearing age . History alcohol abuse , illicit drug use , significant mental illness , physical dependence opioid , history drug abuse addiction within 12 month study enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>111 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>